Journal of Clinical Trials
Open Access

Combating scientific and medical research misconduct and fraud

2^nd International Conference on Clinical Trials and Therapeutic Drug Monitoring

August 22-24, 2016 Philadelphia, USA

Tamera Norton Smith

Norton Audits, Inc., USA

Scientific Tracks Abstracts: J Clin Trials

Abstract :

Clinical research misconduct and fraud continues to impact solid research efforts and increases human research participate risks while participating in vital research efforts. Clinical research professionals need a scientific and valid approach to investigating reports of scientific and medical misconduct and fraud. Join with us as we present the ethical code of conduct for identifying, investigating, resolving and reporting of misconduct and fraud occurrences. The instructor has twenty-six years of experience investigating and auditing misconduct and fraud cases. Case studies will be used to demonstrated time proven skills and techniques for the prevention of misconduct.

Biography :

Tamera Norton Smith has twenty-six years of experience investigating and auditing severe GCP noncompliance. She began her career in GCP and GMP environments in 1990 with the USFDA’s Atlanta and Buffalo Districts. Her passion for FDA’s mission led her to find her own business in 1999 to audit independently and teach responsible research conduct and ethical research practices. She founded Norton Audits in 1999. It was founded on the sole principle that research participants and patients should be safe and protected while vital and effective products are investigated with complete and accurate results and outcomes.

Email: tsmith@nortonaudits.com